Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

High Sensitivity Cardiac Troponin Tests for Acute Myocardial Infarction May be Flawed

By Megan Brooks (Reuters Health) | on March 19, 2019 | 0 Comment
Latest News
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Beckman Coulter provided an unrestricted research grant for the study. The company had no involvement in the data collection, analysis or interpretation, trial design, patient recruitment, writing of the manuscript or decision to submit it for publication. Dr. Curzen received unrestricted research grants from Beckmann Coulter, Boston Scientific, Haemonetics and Heartflow, and speaker fees or consultancy fees from Haemonetics, Abbot Vascular, Heartflow, and Boston Scientific.

You Might Also Like
  • Chest-Pain Patients and High-Sensitivity Troponin Tests: the New Frontier
  • One-hour Acute Myocardial Infarction Rule-Out Not Ready for Prime Time
  • Many Patients Skip Prescribed Drugs After Myocardial Infarction

Pages: 1 2 3 | Single Page

Topics: BiomarkerCardiacCardiac TroponinHeart AttackMyocardial Infarction

Related

  • Discharge Tachycardia: Remember the Big 4 and Don’t Play with Fire

    May 8, 2025 - 2 Comments
  • Readers Respond: Nitroglycerin, Boarding Tactics, and Acute Urinary Retention

    April 1, 2024 - 0 Comment
  • Revisiting Nitroglycerin in MI with Right-Side Ventricular Involvement

    March 5, 2024 - 3 Comments

Current Issue

ACEP Now: November 2025

Download PDF

Read More

No Responses to “High Sensitivity Cardiac Troponin Tests for Acute Myocardial Infarction May be Flawed”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603